Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
Nirav N. Shah, Bryon D. Johnson, Dina Schneider, Fenlu Zhu, Anikó Szabó, Carolyn A. Keever-Taylor, Winfried Krueger, Andrew Worden, Michael J. Kadan, Sharon Yim, Ashley M. Cunningham, Mehdi Hamadani, Timothy S. Fenske, Boro Dropulić, Rimas J. Orentas, Parameswaran Hari
Topics & Concepts
Cytokine release syndromeCD20MedicineCD19B cellRefractory (planetary science)LymphomaChronic lymphocytic leukemiaT cellChimeric antigen receptorImmunologyAntigenLeukemiaInternal medicinePharmacologyImmune systemAntibodyBiologyAstrobiologyCAR-T cell therapy researchNanowire Synthesis and ApplicationsSilicon Carbide Semiconductor Technologies